Regulation & law · 18/10/1996

FDA Approves Injectable Treatment for Horses' Joint Pain

The FDA has approved a new treatment for horses' joint pain, allowing Luitpold Pharmaceuticals to market its polysulfated glycosaminoglycan injectable dosage form for treating noninfectious degenerative and/or traumatic joint dysfunction and associated lameness of the hock joint.